AB Corporate Bond ETF (NASDAQ:EYEG) Declares $0.14 Monthly Dividend

AB Corporate Bond ETF (NASDAQ:EYEGGet Free Report) declared a monthly dividend on Tuesday, June 30th. Stockholders of record on Wednesday, July 1st will be given a dividend of 0.1358 per share by the specialty pharmaceutical company on Tuesday, July 7th. This represents a c) dividend on an annualized basis and a dividend yield of 4.6%. The ex-dividend date is Wednesday, July 1st.

AB Corporate Bond ETF Price Performance

Shares of NASDAQ:EYEG opened at $35.34 on Wednesday. The company has a 50 day moving average of $35.24 and a 200 day moving average of $35.53. The company has a current ratio of 3.07, a quick ratio of 3.07 and a debt-to-equity ratio of 0.01. The stock has a market cap of $28.27 million, a P/E ratio of -21.04 and a beta of 0.17. AB Corporate Bond ETF has a 12 month low of $34.82 and a 12 month high of $36.63.

AB Corporate Bond ETF Company Profile

(Get Free Report)

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.

Further Reading

Dividend History for AB Corporate Bond ETF (NASDAQ:EYEG)

Receive News & Ratings for AB Corporate Bond ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AB Corporate Bond ETF and related companies with MarketBeat.com's FREE daily email newsletter.